Samanta Cimitan Appointed Chief Executive Officer (CEO) at Celonic
Samanta succeeds Dr. Konstantin Matentzoglu, who will step down after 9 years as CEO. During his tenure, Konstantin successfully repositioned the Celonic brand as a premium CDMO, delivered significant growth, and facilitated corporate development and strategic alliances. Konstantin Matentzoglu intends to remain a Member of the Celonic Board and will support Samanta during the transition.
With more than 20 years of experience working, teaching, and studying Life Sciences, Samanta is an expert in the CDMO industry, holding a deep and unique combination of scientific, commercial, and operational know-how.
Samanta joined Celonic in June 2022 as Chief Business Officer (CBO). During this time, she quickly articulated a new strategic direction for the Celonic business, solidified customer relationships, and accelerated innovation.
Prior to Celonic, Samanta was with Lonza for almost 13 years, holding several leadership positions across multiple commercial and strategy roles, including Vice President of Lonza Group Operations Strategy, developing and leading transformational programs across R&D, Operations and Commercial functions. Samanta holds a Ph.D. in Pharmaceutical Sciences from the University of Bologna, Italy, along with a master’s degree in Industrial Chemistry.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.